Search Results

Defibrillation is a means of terminating certain potentially fatal arrhythmias, such as ventricular fibrillation and symptomatic ventricular tachycardia. The AED mode is for use on patients in cardiopulmonary arrest. Pacing is used to treat symptomatic bradycardia and asystole. ECG monitoring is used for identifying and diagnosing cardiac rhythms and dysrhythmias and calculating heart rate. Pulse oximetery is used to check the saturation of in the arterial blood of patients who are at risk of developing hypoxemia.

The LIFEPAK 12 defibrillator/monitor series is a complete acute cardiac response system - battery or auxiliary powered defibrillator (manual and AED), monitor, pacemaker, 3 lead ECG, interpretive 12 lead ECG and pulse oximeter. Data can be transmitted by landline or cell phone to computer, fax, printer, or ECG storage system

The provided 510(k) summary for the Physio-Control LIFEPAK® 12 defibrillator/monitor/pacemaker system does not contain a detailed study with specific acceptance criteria and performance results in the format requested.

Instead, the document states that "Information is provided in the 510(k) regarding compliance to applicable sections of the following voluntary industry standards and FDA guidance documents:" followed by a list of standards for diagnostic electrocardiographic devices, cardiac monitors, cardiac defibrillator devices, and automatic external defibrillators. It concludes by saying, "This information demonstrates that the LIFEPAK 12 is substantially equivalent to the predicate devices with respect to safety, effectiveness, and performance."

Therefore, based on the provided text, I cannot complete the table and answer all points as specific study details are not given. The submission relies on compliance with existing industry standards rather than a new standalone clinical study with explicit acceptance criteria and corresponding performance metrics for the device itself.

Here's a breakdown of what can and cannot be answered:

1. Table of Acceptance Criteria and Reported Device Performance

Not available in the provided text. The document refers to compliance with industry standards, but does not list specific numerical acceptance criteria or performance metrics for the LIFEPAK 12 itself beyond stating substantial equivalence to predicate devices.

2. Sample size used for the test set and the data provenance

Not available in the provided text.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

Not available in the provided text.

4. Adjudication method for the test set

Not available in the provided text.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and if so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. The device described is a defibrillator/monitor/pacemaker system, not an AI-assisted diagnostic tool that would typically involve human readers.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

This is not explicitly stated in the context of a "study" with performance metrics. The device's automated functions (like AED mode) would inherently operate in a "standalone" fashion, but performance data is not provided.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

Not available in the provided text.

8. The sample size for the training set

Not available in the provided text.

9. How the ground truth for the training set was established

Not available in the provided text.

Ask a specific question about this device